reports
KPN proposes to reappoint Gerard van de Aast and Jolande Sap to the Su...
KPN proposes to reappoint Gerard van de Aast and Jolande Sap to the Supervisory Board KPN’s Supervisory Board nominates Mr Gerard van de Aast and Ms Jolande Sap for reappointment to the Supervisory Board. Both nominations will be submitted for voting at the Annual General Meeting of Shareholders (AGM) on 16 April 2025. Mr Gerard van de Aast has been a member of the Supervisory Board since 2021 and is its chair since 2022. The Supervisory Board appreciates his stable and clear chairmanship style and his constant commitment to the company, and therefore proposes to reappoint Mr Van de Aast ...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Jacob Mekhael
- Thomas Vranken
Inventiva FIRST LOOK: Hepalys starts Ph1 with lani for Japan/South Kor...
Inventiva makes progress in its exclusive licensing agreement with Hepalys that was announced in September 2023 to develop and commercialize lanifibranor for the treatment of MASH patients in Japan and South Korea. The first participant has now been dosed in a Ph1 study to assess the safety, tolerability and PK/PD profile of the drug. Upon completion of this study and following Inventiva's EU/US pivotal NATiV3 readout, Inventiva and Hepalys could advance into a pivotal study for the region. We s...
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clin...
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial Initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 studyPositive results could support the initiation of a pivotal Phase 3 trial in patients in Japan with MASHThe study represents the first significant step of Inventiva’s and Hepalys’s partnership toward the development of lanifibranor in Japan and South Korea Daix (France), New York City (New...
Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme ...
Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant dans l'étude de Phase 1 Lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant à l'étude de Phase 1Des résultats positifs pourraient supporter le lancement d'une étude de Phase 3 pivot chez des patients atteints de MASH au JaponCette étude représente la première étape significative du partenariat entre Inventiva et Hepalys Pharma en vue du développement de lanifibranor au Ja...
- ING Helpdesk
Benelux Morning Notes
Aedifica: Good results, positive message about tenants growth. AGEAS: BNP Paribas increase stake >15% ASR: 2H results and SBB in line, capital strength building up. Belgian Telecoms: Peer Telenet 4Q24 results, guiding for low to mid single digit EBITDAal decline EVS: Exceptional FCF, 2025 EBIT consensus to go up >7% on +10-15% like for like sales growth YoY Gimv: In close cooperation with WorxInvest KPN: VodafoneZiggo 4Q24 still weak, declining EBITDA guidance on “strategic customer initiatives”...
- ING Helpdesk
- ING Helpdesk
Benelux Morning Notes
Belgian food retail: Carrefour plans to open all its stores on Sundays. Coca-Cola Europacific Partners: On course for FTSE inclusion. CVC Capital Partners: Stronger for longer. Econocom: REBITA in line but EBIT, net profit and net debt miss materially. Euronext: Strong finish. KPN: New “Althio” tower company deal closed. Recticel: Recovery in the Belgian construction sector expected by 2027F. Umicore: In-line 2024 and 2025 EBITDA guide, dividend cut and rebased. Wereldhave: €167m...
- Hilde Van Boxstael
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
KPN and ABP announce start of new Tower Company “Althio”
KPN and ABP announce start of new Tower Company “Althio” Royal KPN N.V. (KPN) and ABP announce the closing of the transaction to create a new, open Tower Company. Following on 5 June 2024 and the of the Dutch Authority for Consumers & Markets on 6 February 2025, the joint venture named “Althio” () will start its operations as per today. This strategic partnership is in line with KPN's ‘Connect, Activate & Grow’ strategy to optimize the value of its passive infrastructure assets and retain strategic flexibility. Through the creation of Althio, KPN gains higher flexibility over a substanti...
- David Vagman
- CFA
KPN/FCF grounded by inflation, key choice ahead/HOLD
KPN is largely delivering on its very precise guidance, in a rational Dutch market, and benefits from its winning fibre infrastructure over 80% of the Netherlands, including the Glaspoort fibre JV. Now it is also clear there is limited upside to the FCF guidance for 2025-26. We still believe that KPN will eventually need to address the Delta Fiber footprint issue, and we think will end up renting from Delta, a >€200m yearly cost. We think KPN will rapidly reconsolidate its Glaspoort JV, at no co...
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
Inventiva Preliminary FY24 to focus resources, phase 3 enrolment by 1H...
Inventiva reported FY24 revenue and cash results and provided a business update that included the decision to terminate pre-clinical research activities, which will enable the company to focus its resources on its lead program, lanifibranor in MASH. The company continues to guide for completion of enrolment in the phase 3 (NATiV3) trial of lanfibranor in MASH in 1H25, which means topline data is expected in 2H26, positioning NATiV3 as the next phase 3 readout in the MASH landscape. Following the...
Inventiva reports preliminary 2024 fiscal year financial results¹ and ...
Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 million structured financing closed with aggregate gross proceeds of €116 millionLast patient screened in the NATiV3 Phase 3 clinical trial of lanifibranor in MASH early January 2025 and randomization of the last patient expected within the first half of 2025Pipeline prioritization plan presented to the workers council to focus exclusively on the develo...
Inventiva publie ses résultats financiers préliminaires pour l'exercic...
Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité Chiffre d'affaires de 9,2 millions d'euros pour l’année 2024Trésorerie et équivalents de trésorerie à 96,6 millions d’euros au 31 décembre 2024Levée de la première tranche d'un financement structuré d'un montant maximal de 348 millions d'euros, avec un produit brut total de 116 millions d'eurosDernier patient screené dans la Phase 3 de l’étude clinique NATiV3 évaluant lanifibranor dans la MASH début janvier 2025 et randomisation du dernier patient attendue au cours du premi...
KPN successfully issues EUR 800 million senior bond
KPN successfully issues EUR 800 million senior bond Today, Koninklijke KPN N.V. (“KPN”) has successfully issued a € 800 million senior unsecured bond with a 3.375% coupon maturing on 17 February 2035 (the “Bonds”). The new Bonds increase the average maturity of KPN’s outstanding bonds and have been placed with a broad range of institutional investors. The Bonds are issued under KPN’s Global Medium Term Note programme and will be listed on the regulated market of Euronext Dublin. Proceeds will be used for general corporate purposes, including refinancing of existing debt. KPN has a credit ...
- ING Helpdesk
Benelux Morning Notes
Aperam: 4Q24 EBITDA beats on Alloys and Recycling, 1Q25 guidance subdued. Basic-Fit: Consensus released, preview 4Q24/2024 results due 12 March. Flow Traders: 4Q24 preview. IBA: Framatome and IBA to partner to develop Astatine-211 Cyclotron Network. KPN: ACM approval received for new TowerCo with Dutch pension fund ABP. Orange Belgium: Better 2H24 EBITDAal, mobile net adds; 2025 EBITDAal growth guidance. Recticel: Peer Rockwool 4Q24 results. RELX: FY24 preview. Universal Music Gr...
ACM approves creation of new TowerCo by KPN and ABP
ACM approves creation of new TowerCo by KPN and ABP Today, the Netherlands Authority for Consumers and Markets (ACM) has approved the creation of a new tower company (TowerCo). This approval follows the June 05, 2024 that KPN and Dutch pension fund ABP signed an agreement to create this new company. The transaction is expected to close shortly after this regulatory clearance, at which time KPN will provide an update on the financial impact of the transaction. Formal disclosures:Royal KPN N.V. Head of IR: Matthijs van Leijenhorst Inside information: Yes Topic: ACM approves creation of n...
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Dynamic Top Pick List We stick to our selection : No changes in this F...
We stick to our selection : No changes in this February update of our Dynamic Top Pick List. The 13 names are : ABN Amro, Ackermans & van Haaren, Bekaert, D'Ieteren, EVS Broadcast Equipment, Fagron, Fugro, Gimv, Melexis, Shurgard, Sofina, Warehouses De Pauw and Xior. So we continue with 7 cyclical and 6 defensive stocks in our Dynamic Top Pick List with a focus on value stocks that have been left behind. Defensive segment like holdings are overweight, as well as Real-estate that should benefit ...
- Florent Laroche-Joubert
- Roy Külter
COV COVIVIO SA
GFC GECINA SA
NXI NEXITY SA CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
GYC GRAND CITY PROPERTIES SA
MERY MERCIALYS SA
WHA WERELDHAVE N.V.
BLND BRITISH LAND COMPANY PLC
KOF KAUFMAN & BROAD SA
ALTA ALTAREA SCA
VNA VONOVIA SE
XIOR XIOR STUDENT HOUSING N.V.
ICAD ICADE SA
COFB COFINIMMO SA
TEG TAG IMMOBILIEN AG
VASTB VASTNED RETAIL BELGIUM NV
PSPN PSP SWISS PROPERTY AG
SPSN SWISS PRIME SITE AG
PAT PATRIZIA AG
MONT MONTEA SCA
AED AEDIFICA SA
CARM CARMILA SAS
LEG LEG IMMOBILIEN AG
CPINV CARE PROPERTY INVEST SA
ARG ARGAN SA
VGP VGP NV
COL INMOBILIARIA COLONIAL SOCIMI SA
DIC DIC ASSET AG
LRE LAR ESPANA REAL ESTATE SOCIMI SA
MERLIN MERLIN PROPERTIES SOCIMI S.A.
DKG DEUTSCHE KONSUM REIT-AG
HOME NEINOR HOMES SA
AT1 AROUNDTOWN SA
LAND LAND SECURITIES GROUP PLC
MVC METROVACESA SA
NSI NSI N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
INS INSTONE REAL ESTATE GROUP AG
AEDAS AEDAS HOMES SA
WDP WAREHOUSES DE PAUW SCA
ECMPA EUROCOMMERCIAL PROPERTIES NV
CTPNV CTP NV
SHUR SHURGARD SELF STORAGE LIMITED
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.